Comparing TMS stimulation modes for treatment-resistant depression
Part of Mental health clinical trials.
This trial compares different modes of transcranial magnetic stimulation (TMS)—a non-invasive brain stimulation technique—to see which works better for people with treatment-resistant depression. If you've tried multiple antidepressants without relief, this study may offer a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a current diagnosis of major depression without psychotic symptoms.
- You have not responded to at least two different antidepressants, showing moderate to severe treatment resistance.
- Your depression score on a standard 24-item Hamilton scale is 20 or higher.
- You are between 18 and 45 years old.
- You are right-handed.
- You do not have metal objects in your body or other MRI contraindications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two fast types of brain stimulation (called accelerated theta burst stimulation) to see which works better for people whose depression hasn't improved with standard antidepressants. It's designed for people with treatment-resistant depression who are already on a stable antidepressant.
This trial tests a new type of brain stimulation treatment for people with major depression that hasn't improved with standard treatments. The treatment uses magnetic pulses to target specific brain areas over about 2 weeks.
This study tests a type of brain stimulation called cTBS (continuous theta burst stimulation) applied to a specific part of the brain (the precuneus) to see if it helps with treatment-resistant depression. It aims to provide a new option for people who haven't found relief from standard treatments.
This study is testing whether a new type of brain stimulation called intermittent theta burst stimulation (iTBS) can help people with treatment-resistant depression (depression that hasn't improved with standard medicines). It also looks at certain blood markers to see if they can predict how well someone will respond to this treatment.
This study tests a new way of delivering brain stimulation called rTMS to treat depression that hasn't improved with standard treatments. The goal is to see if targeting specific brain areas helps reduce depression symptoms more effectively.
This study tests two methods of targeting repetitive transcranial magnetic stimulation (TMS) for depression: one using brain imaging to guide the treatment, and the other using a standard scalp measurement. The goal is to see if imaging-guided TMS works better for people with treatment-resistant depression.
Hear when a new Treatment Resistant Depression (TRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.